Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
57.9M
-
Shares change
-
+2.38M
-
Total reported value, excl. options
-
$1.36B
-
Value change
-
+$106M
-
Put/Call ratio
-
1.69
-
Number of buys
-
86
-
Number of sells
-
-60
-
Price
-
$23.57
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q2 2020
180 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q2 2020.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.9M shares
of 119M outstanding shares and own 48.51% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.36M shares), VANGUARD GROUP INC (4.57M shares), FMR LLC (3.51M shares), Consonance Capital Management LP (3.35M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (3.11M shares), STATE STREET CORP (3.04M shares), WELLINGTON MANAGEMENT GROUP LLP (3.01M shares), WASATCH ADVISORS INC (2.86M shares), Foresite Capital Management IV, LLC (1.61M shares), and GREAT POINT PARTNERS LLC (1.52M shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.